• 00


  • 00


  • 00


  • 00



Welcome to the NIH P41 Principal Directors Meeting Home Page

The 2015 meeting will be held on Monday and Tuesday March 16th and 17th at the Hilton Washington Hotel, 1750 Rockville Pike, Rockville Maryland.

Technology as a Catalyst

Impacts of Biomedical Technology Resources on Basic Science, Medicine and Innovation

Update 3/12/201

The 2015 Meeting Book is now available

Latest Updates

Update 3/10/2015

The current Agenda (as of 3/10/2015) has been posted. It is located at Eventday/Agenda Agenda »

Meeting Registration

Please click below for meeting registration
View details »

Please click below for sleeping room reservation

View details »

P41 Principal Investigator Meeting

Each year the P41 Principal Investigator Meeting provides an opportunity for the leaders at the various P41 sites to interact with one and other and with the NIGMS and NIBIB leadership. Investigators can also highlight scientific progress at their sites via a poster display on the first day of the meeting. In response to comments received last year we are making several changes to the program. We have also made several changes to the 2015 event website for including an extensive list of restaurants and other points of interest in the Rockville, Maryland area. From this website you will be able to register for the meeting, pay for your meals and book your hotel accommodations. As the various committees complete their work on agenda items and speakers we will update the website’s Event Day Page and provide registrants with the most current information.

Biomedical Technology Resource (P41)

NIBIB's Biomedical Technology Resource Centers (BTRCs) and NIGMS' Biomedical Technology Research Resources (BTRRs) create critical, often unique technology and methods that are at the forefront of their respective fields. These can be a broad range of basic, translational, and clinical research. This is accomplished through a synergistic interaction of technical and biomedical expertise, both within the resources and through intensive collaborations with other leading laboratories.